BIOR - Biora Therapeutics, Inc. Stock Price, Fair Value and News

$0.60-0.03 (-4.76%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BIOR Price Action

Last 7 days

-58.4%

Last 30 days

-77.1%

Last 90 days

-91.2%

Trailing 12 Months

-96.0%

BIOR RSI Chart

BIOR Valuation

Market Cap

2.7M

Price/Earnings (Trailing)

-0.09

Price/Sales (Trailing)

8.9

EV/EBITDA

0.02

Price/Free Cashflow

-0.06

BIOR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BIOR Fundamentals

BIOR Revenue

Revenue (TTM)

305.0K

Rev. Growth (Yr)

-88.49%

Rev. Growth (Qtr)

-89.94%

BIOR Earnings

Earnings (TTM)

-31.5M

Earnings Growth (Yr)

74.95%

Earnings Growth (Qtr)

-384.64%

BIOR Profitability

EBT Margin

-11715.41%

Return on Equity

29.58%

Return on Assets

-217.44%

Free Cashflow Yield

-1.7K%

BIOR Investor Care

Shares Dilution (1Y)

90.80%

Diluted EPS (TTM)

-3.09

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	0
2022	1.2M	828.0K	726.0K	305.0K
2021	414.0K	666.0K	918.0K	1.2M
2020	113.3M	73.3M	36.8M	162.0K
2019	132.0M	136.0M	140.0M	144.0M
2018	0	0	0	128.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Biora Therapeutics, Inc.

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

CEO	Mr. Aditya P. Mohanty M.B.A.
WEBSITE	bioratherapeutics.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	54

Biora Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Biora Therapeutics, Inc.? What does BIOR stand for in stocks?

BIOR is the stock ticker symbol of Biora Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biora Therapeutics, Inc. (BIOR)?

As of Thu Dec 19 2024, market cap of Biora Therapeutics, Inc. is 2.85 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BIOR stock?

You can check BIOR's fair value in chart for subscribers.

Is Biora Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether BIOR is over valued or under valued. Whether Biora Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Biora Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIOR.

What is Biora Therapeutics, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 19 2024, BIOR's PE ratio (Price to Earnings) is -0.09 and Price to Sales (PS) ratio is 31.44. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIOR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Biora Therapeutics, Inc.'s stock?

In the past 10 years, Biora Therapeutics, Inc. has provided -0.32 (multiply by 100 for percentage) rate of return.